666 related articles for article (PubMed ID: 26182507)
1. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
2. [Change in plasma N-terminal pro-brain natriuretic peptide in children with Kawasaki disease and its value in clinical practice].
Zhang QY; Du JB; Chen YH; Li WZ
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):886-90. PubMed ID: 17254452
[TBL] [Abstract][Full Text] [Related]
3. Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease.
Song HB; Zhang YD; Dong QW; Han LP; Qi RF; Bi BB; Ma L; Ma L; Zhang H
J Coll Physicians Surg Pak; 2020 Jan; 30(1):37-40. PubMed ID: 31931930
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
Ye Q; Shao WX; Shang SQ; Zhang T; Hu J; Zhang CC
Arthritis Rheumatol; 2015 Jul; 67(7):1943-50. PubMed ID: 25778686
[TBL] [Abstract][Full Text] [Related]
5. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
Front Immunol; 2021; 12():624802. PubMed ID: 33912155
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between heart rate variability and coronary artery lesion in children with Kawasaki disease].
Chen TT; Shi K; Liu YL; Guo YH; Li Y; Wang XM
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):607-12. PubMed ID: 26108324
[TBL] [Abstract][Full Text] [Related]
7. Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease.
Reddy M; Singh S; Rawat A; Sharma A; Suri D; Rohit MK
Rheumatol Int; 2016 Apr; 36(4):551-9. PubMed ID: 26849890
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of age-adjusted N-terminal prohormone of brain natriuretic peptide level as a diagnostic marker for incomplete Kawasaki disease in children.
Rodríguez-González M; Castellano-Martínez A; Alonso-Ojembarrena A
Emergencias; 2019 Abr; 31(2):111-114. PubMed ID: 30963739
[TBL] [Abstract][Full Text] [Related]
9. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
Zhang XY; He T; Ling JY; Hu XF; Wen Y; Wei J; Lu HL
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide and prediction of coronary artery dilatation in hyperacute phase of Kawasaki disease.
Jung JY; Ham EM; Kwon H; Kwak YH; Kim DK; Lee JH; Jung JH
Am J Emerg Med; 2019 Mar; 37(3):468-471. PubMed ID: 29903669
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
Kaneko K; Yoshimura K; Ohashi A; Kimata T; Shimo T; Tsuji S
Pediatr Cardiol; 2011 Dec; 32(8):1106-9. PubMed ID: 21487793
[TBL] [Abstract][Full Text] [Related]
13. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
14. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y
Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655
[TBL] [Abstract][Full Text] [Related]
15. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M
Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Risk Factors for Coronary Artery Lesion in Children with Kawasaki Disease.
Bai B; Ya JL; Yan C
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1037-1041. PubMed ID: 35932129
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease.
Dionne A; Meloche-Dumas L; Desjardins L; Turgeon J; Saint-Cyr C; Autmizguine J; Spigelblatt L; Fournier A; Dahdah N
Pediatr Int; 2017 Mar; 59(3):265-270. PubMed ID: 27589358
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of IL-6, CRP and NT-proBNP levels in post-COVID multisystem inflammatory syndrome in children (MISC) and Kawasaki disease patients.
Ganguly M; Nandi A; Banerjee P; Gupta P; Sarkar SD; Basu S; Pal P
Int J Rheum Dis; 2022 Jan; 25(1):27-31. PubMed ID: 34750969
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease.
Kwon H; Lee JH; Jung JY; Kwak YH; Kim DK; Jung JH; Chang I; Kim K
Eur J Pediatr; 2016 Dec; 175(12):1997-2003. PubMed ID: 27798729
[TBL] [Abstract][Full Text] [Related]
20. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease.
McNeal-Davidson A; Fournier A; Spigelblatt L; Saint-Cyr C; Mir TS; Nir A; Dallaire F; Cousineau J; Delvin E; Dahdah N
Pediatr Int; 2012 Oct; 54(5):627-33. PubMed ID: 22414326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
